Contact us
Please fill out the details below and we will get back to you shortly.
Thank you!
We will be contacting you soon..
Close
We will be contacting you soon..
Oops! Something went wrong while submitting the form.
Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th. The keynote will be followed by a Q&A session.
Patrick Anquetil, PhD, MBA sat down with ASAP Biopharma ahead of his keynote “Alliance Managers Are Bringing Digital Health Innovation” which is slated for 10:20 a.m. EDT on September 28th. Dr. Anquetil will reveal how Portal’s alliance governance, framework, and execution are inextricably linked to the advancement of this groundbreaking drug-delivery mechanism. After the keynote Dr. Anquetil plans to have a Q&A session and discussion of any aspect of innovation that isn’t covered in his presentation, including but not limited to issues related to regulatory, manufacturing, and commercial phases of the drug development life cycle.
Read the full interview here: ASAP BioPharma Conference Keynote Preview: Alliance Managers Are Bringing Digital Health Innovation
Needles are a 150-year-old technology. The world around us is rapidly evolving but drug delivery has not made the same technological strides that other medical devices have. Portal Instruments is looking to change that with a highly innovative needle-free drug delivery injector.
March 23, 2021, Cambridge, MA The Sumaira Foundation for NMO (TSF) and Portal Instruments are pleased to announce their partnership. Portal Instruments and TSF share a joint vision of creating a better experience and improved treatment options for patients diagnosed with NMOSD.
Portal Instruments was founded with the goal to completely disrupt how injections are given and to replace the needle and syringe with a modern, convenient and safe technology. Our Vision is a Needle-Free World.
Please fill out the details below and we will get back to you shortly.